Recent coverage of our peer-reviewed research, in the healthcare and mainstream press.
Several news organizations covered a paper that discusses the challenges for hospitals in accountable care organizations (ACOs) that also take part in Medicare’s Value-Based Purchasing (VBP) program. Authors from Leavitt Partners, writing in the July issue of The American Journal of Managed Care, find that while ACOs and the Medicare VBP program both seek high quality and cost containment, the 2 programs have different objectives and hospital executives must “create strategies unique to each.” Fierce Healthcare’s Zack Budryk featured the study in his discussion of the exit of 3 participants in Medicare’s Next Generation ACO program, and Becker’s Hospital Review noted the finding that ACO hospitals don’t always perform better than non-ACO peers in Medicare VBP.
Jennifer Bresnick of Health IT Analytics wrote about a separate study in the July issue of The American Journal of Managed Care, in which Mayo Clinic researchers used predictive analytics to identify patients at high risk of ending up in the hospital, especially the emergency department. As Bresnick noted, the tool addresses a high priority for many hospitals and health systems—preventing unnecessary hospitalizations.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More